Exodus Point Capital Management, LP Voyager Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 32,996 shares of VYGR stock, worth $179,828. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,996Holding current value
$179,828% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding VYGR
# of Institutions
130Shares Held
34.7MCall Options Held
39.7KPut Options Held
34.6K-
Black Rock Inc. New York, NY5.31MShares$29 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$28.3 Million0.5% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$21.4 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.19MShares$17.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$12.5 Million0.07% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $211M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...